检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:谢晓强[1] 章振保[1] 杨恩明[1] 李显文[1] 李宗金[2] 徐勇[3]
机构地区:[1]厦门市第二医院泌尿外科,福建厦门361021 [2]南开大学生物活性材料教育部重点实验室 [3]天津市泌尿外科研究所,天津医科大学第二医院泌尿外科
出 处:《临床泌尿外科杂志》2013年第4期300-304,共5页Journal of Clinical Urology
基 金:福建省自然科学基金资助项目(编号2008-59-14)
摘 要:目的:合成Livin靶向的反义核苷酸(ASODN),观察其对前列腺癌PC3细胞凋亡和增殖等生物学特性的影响。方法:合成全硫代磷酸化修饰的Livin ASODN并通过脂质体转染前列腺癌PC3细胞。采用MTT法检测其对细胞增殖的影响,采用RT-PCR检测转染后Livin基因mRNA的表达情况,采用流式细胞仪检测转染后细胞的凋亡效应,采用体内成瘤实验比较细胞在裸鼠体内成瘤性的变化,采用激酶法测定Caspase-3活性的变化。结果:Livin ASODN转染PC3细胞后,与对照组相比,实验组细胞内Livin mRNA的表达水平下调(P<0.01);细胞的增殖受到显著抑制(P<0.01);细胞凋亡率明显增高(P<0.01);肿瘤细胞在荷瘤鼠体内的成瘤体积小于对照组(P<0.05);Caspase-3活性明显增加(P<0.05)。结论:靶向Livin基因的ASODN干扰了前列腺癌PC3细胞中Livin基因的表达,抑制了细胞的增殖并诱导其凋亡,延缓了肿瘤细胞的生长。Objective:To observe the effect of Livin on biology characteristics, such as apoptosis and proliferation, of human prostate cancer cells by antisense oligonucleotide targeting Livin gene. Method:Specific phosphorothioate antisense oligodeoxynucleotides targeting livin were synthesized and then transfected into PC3 cells. Proliferation was detected by MTT assay. The expressions of liven mRNA were detected by Real-time PCR. Cell apoptosis was assayed by flow cytometry. The in vivo tumor growth was observed in nude mice. The activity of Caspase-3 was detected by colorimetric assay. Result: After transfection, down-regulation of Livin mRNA expression in PC3 cells was found (P^0.01). Compared with the control group, the experimental group showed an increase apoptosis rate (P^0.01), a decreased ceil proliferation (P〈0.01), an enhanced caspase-3 activity (P〈0. 05) and bigger tumor size in nude mice (P〈0.05). Conclusion:The antisense oligonucleotide targeting Livin gene was constructed and can knockdown the expression of livin mRNA. It can inhibit PC3 cell proliferation, induce ap- omosis and inhibit tumor growth in vivo.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.217.108.153